Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27350400 | 0.83 | MAPK1 (0.33) | MAPK1APLNR | |
| SCHEMBL295406 | 0.80 | MAPK1 (0.31) | MAPK1 | |
| SCHEMBL1149796 | 0.79 | LMNA (0.32) | MAPK1 | |
| SCHEMBL1149836 | 0.78 | POLA1 (0.35) | ALOX15 | |
| SCHEMBL1149832 | 0.78 | POLA1 (0.35) | ALOX15 | |
| SCHEMBL1150584 | 0.78 | POLA1 (0.35) | ALOX15 | |
| SCHEMBL1149830 | 0.78 | POLA1 (0.35) | ALOX15 | |
| SCHEMBL1150587 | 0.78 | POLA1 (0.35) | ALOX15 | |
| SCHEMBL2709838 | 0.78 | PRKCA (0.30) | — | |
| SCHEMBL1685676 | 0.76 | NAAA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1535895-B1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | SUMITOMO CHEMICAL CO (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20050288526-A1 | Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids | SUMITOMO CHEMICAL COMPAY LIMTED (JP) | 2005-12-29 | — | — | US | disclosed |
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1538141-A1 | PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS | Sumitomo Chemical Company, Limited (JP) | 2005-06-08 | — | — | EP | disclosed |
| EP-1535895-A1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | Sumitomo Chemical Company, Limited (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288526-A1 | Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids | GRHPR, PCCA, C5 | NR1H2 1938/4885MAPK1 1510/4885APLNR 3277/4885 |
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | AHCYL1, HACL2, CBR1 | NR1H2 1525/4885MAPK1 1994/4885APLNR 1844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.